DK1345910T3 - Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf - Google Patents

Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1345910T3
Authority: DK; Denmark
Prior art keywords: compounds; preparation; quinazoline derivatives; drugs containing; drugs
Prior art date: 2000-12-20

Application number

DK01271363T

Other languages

English (en)

Inventor

Anke Baum

Frank Himmelsbach

Elke Langkopf

Stefan Blech

Birgit Jung

Flavio Solca

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-20

Filing date

2001-12-12

Publication date

2009-07-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7667887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1345910(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-12 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2009-07-20 Application granted granted Critical

2009-07-20 Publication of DK1345910T3 publication Critical patent/DK1345910T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

DK01271363T 2000-12-20 2001-12-12 Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf DK1345910T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10063435A DE10063435A1 (de)	2000-12-20	2000-12-20	Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP2001/014569 WO2002050043A1 (de)	2000-12-20	2001-12-12	Chinazolinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung

Publications (1)

Publication Number	Publication Date
DK1345910T3 true DK1345910T3 (da)	2009-07-20

Family

ID=7667887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01271363T DK1345910T3 (da)	2000-12-20	2001-12-12	Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf

Country Status (39)

Country	Link
EP (2)	EP2112140A1 (da)
JP (1)	JP3827641B2 (da)
KR (1)	KR100852102B1 (da)
CN (1)	CN1277822C (da)
AR (1)	AR040524A1 (da)
AT (1)	ATE430136T1 (da)
AU (2)	AU2002219174B2 (da)
BE (1)	BE2014C009I2 (da)
BG (1)	BG66139B1 (da)
BR (1)	BRPI0116266B8 (da)
CA (1)	CA2432428C (da)
CY (2)	CY1109290T1 (da)
CZ (1)	CZ302721B6 (da)
DE (2)	DE10063435A1 (da)
DK (1)	DK1345910T3 (da)
EA (1)	EA006317B1 (da)
EE (1)	EE05244B1 (da)
ES (1)	ES2326617T3 (da)
FR (1)	FR14C0009I2 (da)
HR (1)	HRP20030504B1 (da)
HU (2)	HU228874B1 (da)
IL (2)	IL156277A0 (da)
LT (1)	LTC1345910I2 (da)
LU (1)	LU92370I2 (da)
ME (1)	ME02777B (da)
MX (1)	MXPA03005559A (da)
MY (1)	MY136086A (da)
NO (3)	NO325672B1 (da)
NZ (1)	NZ526918A (da)
PL (1)	PL214798B1 (da)
PT (1)	PT1345910E (da)
RS (1)	RS50860B (da)
SI (1)	SI1345910T1 (da)
SK (1)	SK287573B6 (da)
TW (1)	TWI295992B (da)
UA (1)	UA74614C2 (da)
UY (1)	UY27078A1 (da)
WO (1)	WO2002050043A1 (da)
ZA (1)	ZA200304141B (da)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU90901A (sh)	1999-06-21	2004-07-15	Boehringer Ingelheim Pharma Gmbh. & Co.Kg.	Biciklični heterocikli, lekovi koji sadrže ta jedinjenja, njihova primena i postupci za njihovo pripremanje
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
DE10204462A1 (de) *	2002-02-05	2003-08-07	Boehringer Ingelheim Pharma	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
US20040044014A1 (en)	2002-04-19	2004-03-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
DE10221018A1 (de) *	2002-05-11	2003-11-27	Boehringer Ingelheim Pharma	Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie
PE20040945A1 (es) *	2003-02-05	2004-12-14	Warner Lambert Co	Preparacion de quinazolinas substituidas
DE10307165A1 (de) *	2003-02-20	2004-09-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung
US7223749B2 (en)	2003-02-20	2007-05-29	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
US20050043233A1 (en)	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
DE10334226A1 (de) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
DK1667991T3 (da)	2003-09-16	2008-08-18	Astrazeneca Ab	Quinazolinderivater som tyrosinkinaseinhibitorer
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10349113A1 (de) *	2003-10-17	2005-05-12	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Aminocrotonylverbindungen
AP2204A (en) *	2004-05-06	2011-02-07	Warner Lambert Co	4-phenylamino-quinazolin-6-yl-amides.
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2006081741A1 (en) *	2005-02-05	2006-08-10	Piaoyang Sun	Quinazoline compounds or their medical salts and preparation and medical usage thereof
KR100832594B1 (ko) *	2005-11-08	2008-05-27	한미약품 주식회사	다중저해제로서의 퀴나졸린 유도체 및 이의 제조방법
EP1948179A1 (en)	2005-11-11	2008-07-30	Boehringer Ingelheim International GmbH	Quinazoline derivatives for the treatment of cancer diseases
PL1948180T3 (pl) *	2005-11-11	2013-09-30	Boehringer Ingelheim Int	Terapia skojarzona raka polegająca na podawaniu inhibitorów EGFR/HER2
CA2639936C (en)	2006-01-26	2014-06-17	Boehringer Ingelheim International Gmbh	Process for preparing aminocrotonylamino-substituted quinazoline derivatives
BRPI0717586A2 (pt)	2006-09-18	2013-10-29	Boehringer Ingelheim Int	Método para tratar câncer apresentando mutações do egfr
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
WO2008095847A1 (de)	2007-02-06	2008-08-14	Boehringer Ingelheim International Gmbh	Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US8497369B2 (en)	2008-02-07	2013-07-30	Boehringer Ingelheim International Gmbh	Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production
NZ589883A (en)	2008-05-13	2012-06-29	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy} quinazoline
UY31867A (es)	2008-06-06	2010-01-29	Boehringer Ingelheim Int	Nuevas formulaciones farmacéuticas sólidas que comprenden bibw 2992
US8426430B2 (en)	2008-06-30	2013-04-23	Hutchison Medipharma Enterprises Limited	Quinazoline derivatives
EP2313397B1 (de)	2008-08-08	2016-04-20	Boehringer Ingelheim International GmbH	Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
JP5781934B2 (ja) *	2008-11-10	2015-09-24	ナショナルヘルスリサーチインスティテューツ	チロシンキナーゼ阻害剤としての融合２環および３環ピリミジン化合物
WO2010081817A1 (en)	2009-01-14	2010-07-22	Boehringer Ingelheim International Gmbh	Method for treating colorectal cancer
MY161472A (en)	2009-02-13	2017-04-14	Boehringer Ingelheim Int	Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
WO2010130758A1 (en) *	2009-05-14	2010-11-18	Boehringer Ingelheim International Gmbh	New combination therapy in treatment of cancer and fibrotic diseases
EP2647375A1 (en)	2009-05-14	2013-10-09	Boehringer Ingelheim International Gmbh	Combination of vargatef and dabigatran for the treatment of oncological and fibrotic diseases
PL2451445T3 (pl) *	2009-07-06	2019-09-30	Boehringer Ingelheim International Gmbh	Sposób suszenia BIBW2992, jego soli i stałych preparatów farmaceutycznych zawierających tę substancję czynną
JP2013512882A (ja)	2009-12-07	2013-04-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	トリプルネガティブ乳癌の治療に使用するｂｉｂｗ２９９２
CN105037333A (zh) *	2009-12-21	2015-11-11	张强	新的喹唑啉衍生物
US20120107304A1 (en)	2010-04-27	2012-05-03	Boehringer Ingelheim International Gmbh	Combination therapy in treatment of oncological and fibrotic diseases
PL2608792T3 (pl)	2010-08-26	2018-03-30	Boehringer Ingelheim International Gmbh	Sposoby podawania inhibitora EGFR
KR20130105675A (ko) *	2010-11-25	2013-09-25	라티오팜 게엠베하	아파티닙의 신규 염 및 다형
KR102061743B1 (ko)	2011-03-04	2020-01-03	뉴젠 세러퓨틱스 인코포레이티드	알킨 치환된 퀴나졸린 화합물 및 그것의 사용 방법
CN102918029B (zh) *	2011-05-17	2015-06-17	江苏康缘药业股份有限公司	4-苯胺-6-丁烯酰胺-7-烷醚喹唑啉衍生物及其制备方法和用途
US8828391B2 (en)	2011-05-17	2014-09-09	Boehringer Ingelheim International Gmbh	Method for EGFR directed combination treatment of non-small cell lung cancer
CN102838590B (zh) *	2011-06-21	2014-07-09	苏州迈泰生物技术有限公司	氨基喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
US20150232457A1 (en)	2011-10-06	2015-08-20	Ratiopharm Gmbh	Crystalline forms of afatinib di-maleate
CN103073539B (zh) *	2011-10-26	2016-05-11	齐鲁制药有限公司	4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途
WO2013108754A1 (ja)	2012-01-17	2013-07-25	アステラス製薬株式会社	ピラジンカルボキサミド化合物
CN103772380A (zh) *	2012-10-23	2014-05-07	杨子娇	一类治疗房角狭窄的化合物及其用途
EP2951171A1 (en)	2013-02-01	2015-12-09	Boehringer Ingelheim International GmbH	Radiolabeled quinazoline derivatives
CA2812519A1 (en)	2013-04-05	2014-10-05	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US20140303097A1 (en)	2013-04-05	2014-10-09	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
HRP20190101T1 (hr)	2013-04-05	2019-03-08	Boehringer Ingelheim International Gmbh	Terapeutske uporabe empagliflozina
KR102309654B1 (ko)	2013-04-18	2021-10-08	베링거 인겔하임 인터내셔날 게엠베하	약제학적 조성물, 치료 방법 및 이의 용도
CN103254183B (zh) *	2013-05-10	2015-11-11	苏州明锐医药科技有限公司	阿法替尼的制备方法
CN103254182A (zh) *	2013-05-10	2013-08-21	苏州明锐医药科技有限公司	一种阿法替尼的制备方法
WO2014180271A1 (zh) *	2013-05-10	2014-11-13	苏州明锐医药科技有限公司	阿法替尼及其中间体的制备方法
CN103242303B (zh) *	2013-05-16	2015-03-25	苏州明锐医药科技有限公司	阿法替尼的制备方法
WO2014183560A1 (zh) *	2013-05-16	2014-11-20	苏州明锐医药科技有限公司	阿法替尼及其中间体的制备方法
CN104513229A (zh) *	2013-09-28	2015-04-15	正大天晴药业集团股份有限公司	喹唑啉衍生物及其制备方法
CN103755688B (zh) *	2013-12-24	2015-11-18	江苏奥赛康药业股份有限公司	一种阿法替尼化合物的制备方法
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
EP3089976B1 (en)	2014-01-02	2019-08-14	Teva Pharmaceuticals International GmbH	Crystalline forms of afatinib dimaleate
CN105315263B (zh) *	2014-07-30	2018-11-27	正大天晴药业集团股份有限公司	阿法替尼中间体的合成方法
EP3023421A1 (en)	2014-11-21	2016-05-25	Sandoz Ag	Crystalline forms of afatinib dimaleate
CN105801568B (zh)	2015-01-15	2019-07-30	杭州普晒医药科技有限公司	阿法替尼一马来酸盐晶型及其制备方法和药物组合物
ES2775614T3 (es)	2015-03-20	2020-07-27	Chai Tai Tianqing Pharmaceutical Group Co Ltd	Sales de derivado de quinazolina y método de preparación de las mismas
CN105175400B (zh) *	2015-09-29	2018-04-10	河北神威药业有限公司	一种阿法替尼中间体的制备方法
WO2017141271A1 (en) *	2016-02-17	2017-08-24	Sun Pharmaceutical Industries Ltd.	Stable pharmaceutical composition of afatinib
CN106442793B (zh) *	2016-10-21	2019-05-24	河北神威药业有限公司	一种制备阿法替尼的中间体及其对映异构体的检测方法
CA3039745A1 (en)	2016-11-10	2018-05-17	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
TWI808958B (zh)	2017-01-25	2023-07-21	美商特普醫葯公司	涉及二芳基巨環化合物之組合療法
US11708335B2 (en)	2017-12-18	2023-07-25	Sterngreene, Inc.	Pyrimidine compounds useful as tyrosine kinase inhibitors
CN110437163A (zh) *	2018-05-03	2019-11-12	斯特恩格林公司	作为酪氨酸激酶抑制剂的嘧啶类化合物
KR20210137422A (ko)	2018-09-25	2021-11-17	블랙 다이아몬드 테라퓨틱스, 인코포레이티드	티로신 키나아제 억제제로서의 퀴나졸린 유도체, 조성물, 이들의 제조 방법 및 이들의 용도
CN109265449B (zh) *	2018-11-07	2021-11-23	沈阳工业大学	Egfr和her2双靶点酪氨酸激酶抑制剂及制备方法和用途
CA3124330A1 (en)	2018-12-21	2020-06-25	Daiichi Sankyo Company, Limited	Combination of antibody-drug conjugate and kinase inhibitor
CN109824657A (zh) *	2019-03-26	2019-05-31	石药集团中奇制药技术（石家庄）有限公司	一种二马来酸阿法替尼新晶型及其制备方法和应用
CN119390683A (zh)	2019-08-15	2025-02-07	黑钻治疗公司	炔基喹唑啉化合物
CN110590682A (zh) *	2019-10-14	2019-12-20	重庆医科大学	一种制备阿法替尼杂质的方法以及制备的杂质
US20210161897A1 (en)	2019-11-12	2021-06-03	Astrazeneca Ab	Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
EP4093394A1 (en)	2020-01-20	2022-11-30	Astrazeneca AB	Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
US20210369709A1 (en)	2020-05-27	2021-12-02	Astrazeneca Ab	EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
CN115894383B (zh) *	2021-09-30	2025-12-19	北京赛特明强医药科技有限公司	一种喹唑啉类化合物、组合物及其应用
CN119278041A (zh)	2022-03-31	2025-01-07	阿斯利康(瑞典)有限公司	用于治疗癌症的与akt抑制剂组合的表皮生长因子受体（egfr）酪氨酸激酶抑制剂
WO2023209086A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds for treating cancer
WO2023209088A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds and their use in the treatment of cancer
KR20250006237A (ko)	2022-04-28	2025-01-10	아스트라제네카 아베	축합 바이사이클릭 헤테로방향족 화합물 및 암의 치료에서의 이의 용도
WO2023209090A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds and their application in the treatment of cancer
IL317733A (en)	2022-06-27	2025-02-01	Astrazeneca Ab	Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for cancer treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3370340B2 (ja) *	1996-04-12	2003-01-27	ワーナー―ランバート・コンパニー	チロシンキナーゼの不可逆的阻害剤
ZA986732B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitiors of tyrosine kinases
ZA986729B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitors of tyrosine kinases
DE19911366A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19908567A1 (de) *	1999-02-27	2000-08-31	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
SK12112001A3 (sk) *	1999-02-27	2001-12-03	Boehringer Ingelheim Pharma Kg	4-amino-chinazolínové a chinolínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
DE19911509A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
YU90901A (sh) *	1999-06-21	2004-07-15	Boehringer Ingelheim Pharma Gmbh. & Co.Kg.	Biciklični heterocikli, lekovi koji sadrže ta jedinjenja, njihova primena i postupci za njihovo pripremanje
CA2403152C (en) *	2000-04-08	2008-10-28	Boehringer Ingelheim Pharma Kg	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them

2000
- 2000-12-20 DE DE10063435A patent/DE10063435A1/de not_active Withdrawn
2001
- 2001-12-12 PT PT01271363T patent/PT1345910E/pt unknown
- 2001-12-12 IL IL15627701A patent/IL156277A0/xx unknown
- 2001-12-12 WO PCT/EP2001/014569 patent/WO2002050043A1/de not_active Ceased
- 2001-12-12 DE DE50114874T patent/DE50114874D1/de not_active Expired - Lifetime
- 2001-12-12 NZ NZ526918A patent/NZ526918A/en not_active IP Right Cessation
- 2001-12-12 JP JP2002551540A patent/JP3827641B2/ja not_active Expired - Lifetime
- 2001-12-12 SI SI200130916T patent/SI1345910T1/sl unknown
- 2001-12-12 CN CNB018208665A patent/CN1277822C/zh not_active Expired - Lifetime
- 2001-12-12 UA UA2003076821A patent/UA74614C2/uk unknown
- 2001-12-12 PL PL361798A patent/PL214798B1/pl unknown
- 2001-12-12 HR HR20030504A patent/HRP20030504B1/xx not_active IP Right Cessation
- 2001-12-12 EE EEP200300300A patent/EE05244B1/xx active Protection Beyond IP Right Term
- 2001-12-12 AU AU2002219174A patent/AU2002219174B2/en active Active
- 2001-12-12 MX MXPA03005559A patent/MXPA03005559A/es active IP Right Grant
- 2001-12-12 DK DK01271363T patent/DK1345910T3/da active
- 2001-12-12 CA CA002432428A patent/CA2432428C/en not_active Expired - Lifetime
- 2001-12-12 AT AT01271363T patent/ATE430136T1/de active
- 2001-12-12 SK SK771-2003A patent/SK287573B6/sk not_active IP Right Cessation
- 2001-12-12 EA EA200300671A patent/EA006317B1/ru not_active IP Right Cessation
- 2001-12-12 EP EP09158964A patent/EP2112140A1/de not_active Withdrawn
- 2001-12-12 RS YUP-496/03A patent/RS50860B/sr unknown
- 2001-12-12 HU HU0301852A patent/HU228874B1/hu active Protection Beyond IP Right Term
- 2001-12-12 AU AU1917402A patent/AU1917402A/xx active Pending
- 2001-12-12 KR KR1020037008246A patent/KR100852102B1/ko not_active Expired - Lifetime
- 2001-12-12 BR BRPI0116266A patent/BRPI0116266B8/pt not_active IP Right Cessation
- 2001-12-12 EP EP01271363.2A patent/EP1345910B9/de not_active Expired - Lifetime
- 2001-12-12 CZ CZ20031930A patent/CZ302721B6/cs not_active IP Right Cessation
- 2001-12-12 ME MEP-2008-595A patent/ME02777B/me unknown
- 2001-12-12 ES ES01271363T patent/ES2326617T3/es not_active Expired - Lifetime
- 2001-12-17 UY UY27078A patent/UY27078A1/es not_active Application Discontinuation
- 2001-12-19 TW TW090131520A patent/TWI295992B/zh active
- 2001-12-19 AR AR20010105883A patent/AR040524A1/es active IP Right Grant
- 2001-12-19 MY MYPI20015767A patent/MY136086A/en unknown
2003
- 2003-05-28 ZA ZA200304141A patent/ZA200304141B/en unknown
- 2003-06-03 IL IL156277A patent/IL156277A/en active Protection Beyond IP Right Term
- 2003-06-16 NO NO20032726A patent/NO325672B1/no active Protection Beyond IP Right Term
- 2003-06-19 BG BG107929A patent/BG66139B1/bg unknown
2009
- 2009-07-23 CY CY20091100793T patent/CY1109290T1/el unknown
2014
- 2014-01-30 FR FR14C0009C patent/FR14C0009I2/fr active Active
- 2014-01-31 LU LU92370C patent/LU92370I2/fr unknown
- 2014-02-06 LT LTPA2014005C patent/LTC1345910I2/lt unknown
- 2014-02-11 NO NO2014003C patent/NO2014003I2/no not_active IP Right Cessation
- 2014-02-12 HU HUS1400005C patent/HUS1400005I1/hu unknown
- 2014-02-12 CY CY2014008C patent/CY2014008I2/el unknown
- 2014-02-18 BE BE2014C009C patent/BE2014C009I2/fr unknown
2022
- 2022-07-01 NO NO2022028C patent/NO2022028I1/no unknown

Also Published As

Publication number	Publication date
EP1345910A1 (de)	2003-09-24
AU1917402A (en)	2002-07-01
BRPI0116266B8 (pt)	2021-07-27
HRP20030504B1 (en)	2011-09-30
CN1481370A (zh)	2004-03-10
EA200300671A1 (ru)	2004-06-24
LU92370I9 (da)	2019-01-17
DE50114874D1 (de)	2009-06-10
NO325672B1 (no)	2008-07-07
BR0116266A (pt)	2004-02-17
PL361798A1 (en)	2004-10-04
HU228874B1 (en)	2013-06-28
LTPA2014005I1 (lt)	2022-05-25
IL156277A (en)	2009-12-24
MY136086A (en)	2008-08-29
LU92370I2 (fr)	2014-03-31
IL156277A0 (en)	2004-01-04
NO20032726D0 (no)	2003-06-16
HUP0301852A3 (en)	2008-03-28
KR100852102B1 (ko)	2008-08-13
WO2002050043A1 (de)	2002-06-27
LTC1345910I2 (lt)	2022-06-10
NO2022028I1 (no)	2022-07-01
SK7712003A3 (en)	2003-10-07
NO20032726L (no)	2003-06-16
MEP59508A (en)	2011-05-10
BG107929A (bg)	2005-01-31
SK287573B6 (sk)	2011-03-04
RS50860B (sr)	2010-08-31
YU49603A (sh)	2006-05-25
EP1345910B1 (de)	2009-04-29
CZ302721B6 (cs)	2011-09-21
DE10063435A1 (de)	2002-07-04
BE2014C009I2 (da)	2021-02-04
SI1345910T1 (sl)	2009-08-31
UY27078A1 (es)	2002-07-31
EP1345910B9 (de)	2014-06-04
KR20030071787A (ko)	2003-09-06
NO2014003I2 (no)	2015-10-19
AU2002219174B2 (en)	2007-09-06
UA74614C2 (en)	2006-01-16
PL214798B1 (pl)	2013-09-30
EP2112140A1 (de)	2009-10-28
HUP0301852A2 (hu)	2003-09-29
CA2432428C (en)	2009-09-01
FR14C0009I2 (fr)	2014-11-14
EE05244B1 (et)	2009-12-15
ES2326617T9 (es)	2014-09-10
CY1109290T1 (el)	2014-07-02
CZ20031930A3 (cs)	2003-10-15
BG66139B1 (bg)	2011-07-29
MXPA03005559A (es)	2004-10-14
ES2326617T3 (es)	2009-10-16
ZA200304141B (en)	2004-04-15
NZ526918A (en)	2006-11-30
PT1345910E (pt)	2009-07-14
AR040524A1 (es)	2005-04-13
JP2004516283A (ja)	2004-06-03
BRPI0116266B1 (pt)	2017-10-31
ATE430136T1 (de)	2009-05-15
CY2014008I2 (el)	2015-12-09
EA006317B1 (ru)	2005-10-27
EE200300300A (et)	2003-10-15
CN1277822C (zh)	2006-10-04
FR14C0009I1 (fr)	2014-03-07
ME02777B (me)	2011-10-10
HRP20030504A2 (en)	2005-06-30
NO2014003I1 (no)	2014-06-02
CY2014008I1 (el)	2014-07-02
HK1060571A1 (en)	2004-08-13
HUS1400005I1 (hu)	2017-08-28
JP3827641B2 (ja)	2006-09-27
TWI295992B (en)	2008-04-21
CA2432428A1 (en)	2002-06-27

Publication	Publication Date	Title
NO20024175D0 (no)	2002-09-02	Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20032733L (no)	2003-08-14	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO20032726L (no)	2003-06-16	Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
DK1180518T3 (da)	2007-05-21	5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1294682T3 (da)	2004-08-02	Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20014603L (no)	2001-11-26	Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20014013D0 (no)	2001-08-17	16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
NO20011216L (no)	2001-05-09	Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
IS6310A (is)	2002-03-19	Kínasólínafleiður til lækninga
DK1218341T3 (da)	2005-12-12	Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20015113D0 (no)	2001-10-19	Nye forbindelser, deres fremstilling og anvendelse
NO20024742L (no)	2002-11-25	Heterocykliske forbindelser, deres fremstilling og anvendelse
DK1083171T3 (da)	2004-08-09	Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
MXPA03000873A (es)	2003-06-06	Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
DK1381605T3 (da)	2005-05-09	Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20016038L (no)	2002-02-11	Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
NO20031273L (no)	2003-05-14	Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
NO20005146D0 (no)	2000-10-13	Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1674456T3 (da)	2008-10-27	Nye 1,4-benzothiazepin-1,1-dioxid-derivater med forbedrede egenskaber, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
DK1098891T3 (da)	2005-12-12	Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
DK1118610T3 (da)	2002-12-16	Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
DK1086077T3 (da)	2004-08-02	Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DK1341758T3 (da)	2006-10-30	Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme